4/A//SEC Filing
Valantine Hannah 4/A
Accession 0000950170-25-091759
CIK 0001743881other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 5:49 PM ET
Size
5.1 KB
Accession
0000950170-25-091759
Insider Transaction Report
Form 4/AAmended
Valantine Hannah
Director
Transactions
- Purchase
Common Stock
2021-12-29$14.24/sh+1,752$24,948→ 3,294 total
Holdings
- 2,687(indirect: By Spouse)
Common Stock
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001855608
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 5:49 PM ET
- Size
- 5.1 KB